Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging

References

• Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–e203. doi:10.1016/S2214-109X(19)30482-631812369
   PubMed Web of Science ®Google Scholar
• Ping L. Evaluation of big data of clinical epidemiology of cervical cancer in 13 years in Chinese mainland (in Chinese).Chinese JPractical Gynecology and Obstetrics.. 2018;34(01):41–45.
   Google Scholar
• Toita T, Nakano M, Higashi M, Sakumoto K, Kanazawa K. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for pa tients with uterine cervical cancer treated by radical radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33(4):843–849. doi:10.1016/0360-3016(95)00204-57591892
   PubMed Web of Science ®Google Scholar
• Kobierski J, Emerich J, Kr¨®likowska B, Majdak E. [Lymph node metastasis as a prognostic factor in cervical carcinoma]. Ginekol Pol. 2002;73(11):925–929. Polish12722375
   PubMedGoogle Scholar
• Yan X, Li G, Shang H, Lin F, Yang X, Zheng F. Outcome and prognostic factors of laparoscopic radical hysterectomy and pelvic lymphadenectomy in 148 patients with stage IB1 cervical cancer. Int J Gynecol Cancer. 2012;22(2):286–290. doi:10.1097/IGC.0b013e318233d54922146764
   PubMed Web of Science ®Google Scholar
• Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143(Suppl 2):22–36. doi:10.1002/ijgo.1261130306584
   PubMed Web of Science ®Google Scholar
• Tomizawa K, Kaminuma T, Murata K, et al. FIGO 2018 staging for cervical cancer: influence on stage distribution and outcomes in the 3D-image-G uided brachytherapy era. Cancers. 2020;12(7):1770. doi:10.3390/cancers12071770
   PubMed Web of Science ®Google Scholar
• Brodeur MN, Dejean R, Beauchemin MC, et al. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer. Gynecol Oncol. 2021;162(2):277–283. doi:10.1016/j.ygyno.2021.05.02334059350
   PubMed Web of Science ®Google Scholar
• Lan C, Shen J, Wang Y, et al. Camrelizumab plus apatinib in patients with advanced cervical cancer (CLAP): a multicenter, open-label, single-arm, phase II trial. J Clin Oncol. 2020;38(34):4095–4106. doi:10.1200/JCO.20.0192033052760
   PubMed Web of Science ®Google Scholar
• Matsuo K, Machida H, Mandelbaum RS, Konishi I, Mikami M. Validation of the 2018 FIGO cervical cancer staging system. Gynecol Oncol. 2019;152(1):87–93. doi:10.1016/j.ygyno.2018.10.02630389105
   PubMed Web of Science ®Google Scholar
• Tang X, Guo C, Liu S, Guo J, Hua K, Qiu J. A novel prognostic nomogram utilizing the 2018 FIGO staging system for cervical cancer: a large multi center study. Int J Gynaecol Obstet. 2021;155(1):86–94. doi:10.1002/ijgo.13644
   PubMed Web of Science ®Google Scholar
• Rose PG, Java J, Whitney CW, et al. Nomograms predicting progression-free survival, overall survival, and pelvic recurrence in locally advanced cervical cancer developed from an analysis of identifiable prognostic factors in patients from NRG oncology/Gynecologic oncology group randomized trials of chemoradiotherapy. J Clin Oncol. 2015;33(19):2136–2142. doi:10.1200/JCO.2014.57.712225732170
   PubMed Web of Science ®Google Scholar
• Marchetti C, De Felice F, Di Pinto A, et al. Survival nomograms after curative neoadjuvant chemotherapy and radical surgery for stage IB2-IIIB cervical cancer. Cancer Res Treat. 2018;50(3):768–776. doi:10.4143/crt.2017.14128724282
   PubMed Web of Science ®Google Scholar
• Yang J, Tian G, Pan Z, et al. Nomograms for predicting the survival rate for cervical cancer patients who undergo radiation therapy: a SEER analysis. Fut Oncol. 2019;15(26):3033–3045. doi:10.2217/fon-2019-0029
   PubMed Web of Science ®Google Scholar
• Sturdza AE, P?tter R, Kossmeier M, et al. Nomogram predicting overall survival in patients with locally advanced cervical cancer treated with r adiochemotherapy including image-guided brachytherapy: a retro-EMBRACE study. Int J Radiat Oncol Biol Phys. 2021;111(1):168–177. doi:10.1016/j.ijrobp.2021.04.02233932530
   PubMed Web of Science ®Google Scholar
• Xie G, Wang R, Shang L, et al. Calculating the overall survival probability in patients with cervical cancer: a nomogram and decisio n curve analysis-based study. BMC Cancer. 2020;20(1):833. doi:10.1186/s12885-020-07349-432873257
   PubMed Web of Science ®Google Scholar
• Polterauer S, Grimm C, Hofstetter G, et al. Nomogram prediction for overall survival of patients diagnosed with cervical cancer. Br J Cancer. 2012;107(6):918–924. doi:10.1038/bjc.2012.34022871885
   PubMed Web of Science ®Google Scholar
• Padilla LA, Radosevich DM, Milad MP. Limitations of the pelvic examination for evaluation of the female pelvic organs. Int J Gynaecol Obstet. 2005;88(1):84–88. doi:10.1016/j.ijgo.2004.09.01515617719
   PubMed Web of Science ®Google Scholar
• Wang J, Wang T, Yang YY, Chai YL, Shi F, Liu ZI. Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer. Mol Clin Oncol. 2015;3(2):363–366. doi:10.3892/mco.2014.46525798268
   PubMedGoogle Scholar
• Stanley JA, Shipley WU, Steel GG. Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour. Br J Cancer. 1977;36(1):105–113. doi:10.1038/bjc.1977.160889677
   PubMed Web of Science ®Google Scholar
• Wang J, Klem J, Wyrick JB, et al. Detection of hypoxia in human brain tumor xenografts using a modified comet assay. Neoplasia. 2003;5(4):288–296. doi:10.1016/S1476-5586(03)80022-214511400
   PubMed Web of Science ®Google Scholar
• Bae HS, Kim YJ, Lim MC, et al. Predictors of radiation field failure after definitive chemoradiation in patients with locally advanc ed cervical cancer. Int J Gynecol Cancer. 2016;26(4):737–742. doi:10.1097/IGC.000000000000066226937749
   PubMed Web of Science ®Google Scholar
• Kim H, Cho WK, Kim YJ, Kim YS, Park W. Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy. Gynecol Oncol. 2020;157(2):423–428. doi:10.1016/j.ygyno.2020.02.03132139148
   PubMed Web of Science ®Google Scholar
• Chen X, Chen L, Zhu H, Tao J. Risk factors and prognostic predictors for cervical cancer patients with lung metastasis. J Cancer. 2020;11(20):5880–5889. doi:10.7150/jca.4625832922530
   PubMed Web of Science ®Google Scholar
• Kilic C, Kimyon Comert G, Cakir C, et al. Recurrence pattern and prognostic factors for survival in cervical cancer with lymph node metastasis. J Obstet Gynaecol Res. 2021;47(6):2175–2184. doi:10.1111/jog.1476233765693
   PubMed Web of Science ®Google Scholar
• Grigsby PW, Massad LS, Mutch DG, et al. FIGO 2018 staging criteria for cervical cancer: impact on stage migration and survival. Gynecol Oncol. 2020;157(3):639–643. doi:10.1016/j.ygyno.2020.03.02732248993
   PubMed Web of Science ®Google Scholar
• Gurram L, Patil R, Chopra S, et al. Evaluation of outcomes in patients of cervical cancer with lower one third vaginal involvement: a single institutional experience. Gynecol Oncol. 2020;159(2):359–364. doi:10.1016/j.ygyno.2020.08.01132829963
   PubMed Web of Science ®Google Scholar
• Katanyoo K. Comparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lo wer third of vaginal invasion. J Gynecol Oncol. 2017;28(6):e79.29027397
   PubMed Web of Science ®Google Scholar
• Fang C, Zhang P, Yu A, Yang Y, Zhang J. Different prognosis of stage IIIB cervical cancer patients with lower third of vaginal invasion and t hose without. Gynecol Oncol. 2021;162(1):50–55. doi:10.1016/j.ygyno.2021.04.00533858676
   PubMed Web of Science ®Google Scholar
• Innocenti P, Pulli F, Savino L, et al. Staging of cervical cancer: reliability of transrectal US. Radiology. 1992;185(1):201–205. doi:10.1148/radiology.185.1.15233081523308
   PubMed Web of Science ®Google Scholar
• Yang WT, Walkden SB, Ho S, et al. Transrectal ultrasound in the evaluation of cervical carcinoma and comparison with spiral computed to mography and magnetic resonance imaging. Br J Radiol. 1996;69(823):610–616.8696696
   PubMed Web of Science ®Google Scholar
• Qin Y, Peng Z, Lou J, Liu H, Deng F, Zheng Y. Discrepancies between clinical staging and pathological findings of operable cervical carcinoma with stage IB-IIB: a retrospective analysis of 818 patients. Aust N Z J Obstet Gynaecol. 2009;49(5):542–544. doi:10.1111/j.1479-828X.2009.01065.x19780741
   PubMed Web of Science ®Google Scholar
• Kim SH, Choi BI, Lee HP, et al. Uterine cervical carcinoma: comparison of CT and MR findings. Radiology. 1990;175(1):45–51. doi:10.1148/radiology.175.1.23155032315503
   PubMed Web of Science ®Google Scholar